Global Antispasmodics Drug Market Growth (Status and Outlook) 2025-2031

September 2025 | 113 pages | ID: GA9034AF3E90EN
LP Information

Abstracts

According to this study, the global Antispasmodics Drug market size will reach US$ million by 2031.

It is a drug that suppresses muscle spasms, a type of antispasmodic used for smooth muscle contraction, especially in the tubular organs of the gastrointestinal tract.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Antispasmodics Drug Industry Forecast” looks at past sales and reviews total world Antispasmodics Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Antispasmodics Drug sales for 2025 through 2031. With Antispasmodics Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antispasmodics Drug industry.

This Insight Report provides a comprehensive analysis of the global Antispasmodics Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Antispasmodics Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antispasmodics Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antispasmodics Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antispasmodics Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Antispasmodics Drug market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Dicyclomine Hydrochloride
• Loperamide Hydrochloride
• Others

Segmentation by Application:

• Hospital
• Homecare
• Specialty Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Allergan
• Hikma Pharmaceutical
• Lannett
• Mylan
• Nexus Pharmaceuticals
• Akorn
• Aurobindo Pharma
• Daiichi Sankyo
• Fresenius Kabi
• Shanghai Fosun Pharmaceutical?Group?
• SunGen Pharma

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Antispasmodics Drug Market Size (2020-2031)
  2.1.2 Antispasmodics Drug Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Antispasmodics Drug by Country/Region (2020, 2024 & 2031)
2.2 Antispasmodics Drug Segment by Type
  2.2.1 Dicyclomine Hydrochloride
  2.2.2 Loperamide Hydrochloride
  2.2.3 Others
2.3 Antispasmodics Drug Market Size by Type
  2.3.1 Antispasmodics Drug Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Antispasmodics Drug Market Size Market Share by Type (2020-2025)
2.4 Antispasmodics Drug Segment by Application
  2.4.1 Hospital
  2.4.2 Homecare
  2.4.3 Specialty Clinic
  2.4.4 Others
2.5 Antispasmodics Drug Market Size by Application
  2.5.1 Antispasmodics Drug Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Antispasmodics Drug Market Size Market Share by Application (2020-2025)

3 ANTISPASMODICS DRUG MARKET SIZE BY PLAYER

3.1 Antispasmodics Drug Market Size Market Share by Player
  3.1.1 Global Antispasmodics Drug Revenue by Player (2020-2025)
  3.1.2 Global Antispasmodics Drug Revenue Market Share by Player (2020-2025)
3.2 Global Antispasmodics Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANTISPASMODICS DRUG BY REGION

4.1 Antispasmodics Drug Market Size by Region (2020-2025)
4.2 Global Antispasmodics Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antispasmodics Drug Market Size Growth (2020-2025)
4.4 APAC Antispasmodics Drug Market Size Growth (2020-2025)
4.5 Europe Antispasmodics Drug Market Size Growth (2020-2025)
4.6 Middle East & Africa Antispasmodics Drug Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Antispasmodics Drug Market Size by Country (2020-2025)
5.2 Americas Antispasmodics Drug Market Size by Type (2020-2025)
5.3 Americas Antispasmodics Drug Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Antispasmodics Drug Market Size by Region (2020-2025)
6.2 APAC Antispasmodics Drug Market Size by Type (2020-2025)
6.3 APAC Antispasmodics Drug Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Antispasmodics Drug Market Size by Country (2020-2025)
7.2 Europe Antispasmodics Drug Market Size by Type (2020-2025)
7.3 Europe Antispasmodics Drug Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Antispasmodics Drug by Region (2020-2025)
8.2 Middle East & Africa Antispasmodics Drug Market Size by Type (2020-2025)
8.3 Middle East & Africa Antispasmodics Drug Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ANTISPASMODICS DRUG MARKET FORECAST

10.1 Global Antispasmodics Drug Forecast by Region (2026-2031)
  10.1.1 Global Antispasmodics Drug Forecast by Region (2026-2031)
  10.1.2 Americas Antispasmodics Drug Forecast
  10.1.3 APAC Antispasmodics Drug Forecast
  10.1.4 Europe Antispasmodics Drug Forecast
  10.1.5 Middle East & Africa Antispasmodics Drug Forecast
10.2 Americas Antispasmodics Drug Forecast by Country (2026-2031)
  10.2.1 United States Market Antispasmodics Drug Forecast
  10.2.2 Canada Market Antispasmodics Drug Forecast
  10.2.3 Mexico Market Antispasmodics Drug Forecast
  10.2.4 Brazil Market Antispasmodics Drug Forecast
10.3 APAC Antispasmodics Drug Forecast by Region (2026-2031)
  10.3.1 China Antispasmodics Drug Market Forecast
  10.3.2 Japan Market Antispasmodics Drug Forecast
  10.3.3 Korea Market Antispasmodics Drug Forecast
  10.3.4 Southeast Asia Market Antispasmodics Drug Forecast
  10.3.5 India Market Antispasmodics Drug Forecast
  10.3.6 Australia Market Antispasmodics Drug Forecast
10.4 Europe Antispasmodics Drug Forecast by Country (2026-2031)
  10.4.1 Germany Market Antispasmodics Drug Forecast
  10.4.2 France Market Antispasmodics Drug Forecast
  10.4.3 UK Market Antispasmodics Drug Forecast
  10.4.4 Italy Market Antispasmodics Drug Forecast
  10.4.5 Russia Market Antispasmodics Drug Forecast
10.5 Middle East & Africa Antispasmodics Drug Forecast by Region (2026-2031)
  10.5.1 Egypt Market Antispasmodics Drug Forecast
  10.5.2 South Africa Market Antispasmodics Drug Forecast
  10.5.3 Israel Market Antispasmodics Drug Forecast
  10.5.4 Turkey Market Antispasmodics Drug Forecast
10.6 Global Antispasmodics Drug Forecast by Type (2026-2031)
10.7 Global Antispasmodics Drug Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Antispasmodics Drug Forecast

11 KEY PLAYERS ANALYSIS

11.1 Allergan
  11.1.1 Allergan Company Information
  11.1.2 Allergan Antispasmodics Drug Product Offered
  11.1.3 Allergan Antispasmodics Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Allergan Main Business Overview
  11.1.5 Allergan Latest Developments
11.2 Hikma Pharmaceutical
  11.2.1 Hikma Pharmaceutical Company Information
  11.2.2 Hikma Pharmaceutical Antispasmodics Drug Product Offered
  11.2.3 Hikma Pharmaceutical Antispasmodics Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Hikma Pharmaceutical Main Business Overview
  11.2.5 Hikma Pharmaceutical Latest Developments
11.3 Lannett
  11.3.1 Lannett Company Information
  11.3.2 Lannett Antispasmodics Drug Product Offered
  11.3.3 Lannett Antispasmodics Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Lannett Main Business Overview
  11.3.5 Lannett Latest Developments
11.4 Mylan
  11.4.1 Mylan Company Information
  11.4.2 Mylan Antispasmodics Drug Product Offered
  11.4.3 Mylan Antispasmodics Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Mylan Main Business Overview
  11.4.5 Mylan Latest Developments
11.5 Nexus Pharmaceuticals
  11.5.1 Nexus Pharmaceuticals Company Information
  11.5.2 Nexus Pharmaceuticals Antispasmodics Drug Product Offered
  11.5.3 Nexus Pharmaceuticals Antispasmodics Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Nexus Pharmaceuticals Main Business Overview
  11.5.5 Nexus Pharmaceuticals Latest Developments
11.6 Akorn
  11.6.1 Akorn Company Information
  11.6.2 Akorn Antispasmodics Drug Product Offered
  11.6.3 Akorn Antispasmodics Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Akorn Main Business Overview
  11.6.5 Akorn Latest Developments
11.7 Aurobindo Pharma
  11.7.1 Aurobindo Pharma Company Information
  11.7.2 Aurobindo Pharma Antispasmodics Drug Product Offered
  11.7.3 Aurobindo Pharma Antispasmodics Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Aurobindo Pharma Main Business Overview
  11.7.5 Aurobindo Pharma Latest Developments
11.8 Daiichi Sankyo
  11.8.1 Daiichi Sankyo Company Information
  11.8.2 Daiichi Sankyo Antispasmodics Drug Product Offered
  11.8.3 Daiichi Sankyo Antispasmodics Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Daiichi Sankyo Main Business Overview
  11.8.5 Daiichi Sankyo Latest Developments
11.9 Fresenius Kabi
  11.9.1 Fresenius Kabi Company Information
  11.9.2 Fresenius Kabi Antispasmodics Drug Product Offered
  11.9.3 Fresenius Kabi Antispasmodics Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Fresenius Kabi Main Business Overview
  11.9.5 Fresenius Kabi Latest Developments
11.10 Shanghai Fosun Pharmaceutical?Group?
  11.10.1 Shanghai Fosun Pharmaceutical?Group? Company Information
  11.10.2 Shanghai Fosun Pharmaceutical?Group? Antispasmodics Drug Product Offered
  11.10.3 Shanghai Fosun Pharmaceutical?Group? Antispasmodics Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Shanghai Fosun Pharmaceutical?Group? Main Business Overview
  11.10.5 Shanghai Fosun Pharmaceutical?Group? Latest Developments
11.11 SunGen Pharma
  11.11.1 SunGen Pharma Company Information
  11.11.2 SunGen Pharma Antispasmodics Drug Product Offered
  11.11.3 SunGen Pharma Antispasmodics Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 SunGen Pharma Main Business Overview
  11.11.5 SunGen Pharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Antispasmodics Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Antispasmodics Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Dicyclomine Hydrochloride
Table 4. Major Players of Loperamide Hydrochloride
Table 5. Major Players of Others
Table 6. Antispasmodics Drug Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Antispasmodics Drug Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Antispasmodics Drug Market Size Market Share by Type (2020-2025)
Table 9. Antispasmodics Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Antispasmodics Drug Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Antispasmodics Drug Market Size Market Share by Application (2020-2025)
Table 12. Global Antispasmodics Drug Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Antispasmodics Drug Revenue Market Share by Player (2020-2025)
Table 14. Antispasmodics Drug Key Players Head office and Products Offered
Table 15. Antispasmodics Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Antispasmodics Drug Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Antispasmodics Drug Market Size Market Share by Region (2020-2025)
Table 20. Global Antispasmodics Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Antispasmodics Drug Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Antispasmodics Drug Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Antispasmodics Drug Market Size Market Share by Country (2020-2025)
Table 24. Americas Antispasmodics Drug Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Antispasmodics Drug Market Size Market Share by Type (2020-2025)
Table 26. Americas Antispasmodics Drug Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Antispasmodics Drug Market Size Market Share by Application (2020-2025)
Table 28. APAC Antispasmodics Drug Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Antispasmodics Drug Market Size Market Share by Region (2020-2025)
Table 30. APAC Antispasmodics Drug Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Antispasmodics Drug Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Antispasmodics Drug Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Antispasmodics Drug Market Size Market Share by Country (2020-2025)
Table 34. Europe Antispasmodics Drug Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Antispasmodics Drug Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Antispasmodics Drug Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Antispasmodics Drug Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Antispasmodics Drug Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Antispasmodics Drug
Table 40. Key Market Challenges & Risks of Antispasmodics Drug
Table 41. Key Industry Trends of Antispasmodics Drug
Table 42. Global Antispasmodics Drug Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Antispasmodics Drug Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Antispasmodics Drug Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Antispasmodics Drug Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Allergan Details, Company Type, Antispasmodics Drug Area Served and Its Competitors
Table 47. Allergan Antispasmodics Drug Product Offered
Table 48. Allergan Antispasmodics Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Allergan Main Business
Table 50. Allergan Latest Developments
Table 51. Hikma Pharmaceutical Details, Company Type, Antispasmodics Drug Area Served and Its Competitors
Table 52. Hikma Pharmaceutical Antispasmodics Drug Product Offered
Table 53. Hikma Pharmaceutical Antispasmodics Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Hikma Pharmaceutical Main Business
Table 55. Hikma Pharmaceutical Latest Developments
Table 56. Lannett Details, Company Type, Antispasmodics Drug Area Served and Its Competitors
Table 57. Lannett Antispasmodics Drug Product Offered
Table 58. Lannett Antispasmodics Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Lannett Main Business
Table 60. Lannett Latest Developments
Table 61. Mylan Details, Company Type, Antispasmodics Drug Area Served and Its Competitors
Table 62. Mylan Antispasmodics Drug Product Offered
Table 63. Mylan Antispasmodics Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Mylan Main Business
Table 65. Mylan Latest Developments
Table 66. Nexus Pharmaceuticals Details, Company Type, Antispasmodics Drug Area Served and Its Competitors
Table 67. Nexus Pharmaceuticals Antispasmodics Drug Product Offered
Table 68. Nexus Pharmaceuticals Antispasmodics Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Nexus Pharmaceuticals Main Business
Table 70. Nexus Pharmaceuticals Latest Developments
Table 71. Akorn Details, Company Type, Antispasmodics Drug Area Served and Its Competitors
Table 72. Akorn Antispasmodics Drug Product Offered
Table 73. Akorn Antispasmodics Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Akorn Main Business
Table 75. Akorn Latest Developments
Table 76. Aurobindo Pharma Details, Company Type, Antispasmodics Drug Area Served and Its Competitors
Table 77. Aurobindo Pharma Antispasmodics Drug Product Offered
Table 78. Aurobindo Pharma Antispasmodics Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Aurobindo Pharma Main Business
Table 80. Aurobindo Pharma Latest Developments
Table 81. Daiichi Sankyo Details, Company Type, Antispasmodics Drug Area Served and Its Competitors
Table 82. Daiichi Sankyo Antispasmodics Drug Product Offered
Table 83. Daiichi Sankyo Antispasmodics Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Daiichi Sankyo Main Business
Table 85. Daiichi Sankyo Latest Developments
Table 86. Fresenius Kabi Details, Company Type, Antispasmodics Drug Area Served and Its Competitors
Table 87. Fresenius Kabi Antispasmodics Drug Product Offered
Table 88. Fresenius Kabi Antispasmodics Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Fresenius Kabi Main Business
Table 90. Fresenius Kabi Latest Developments
Table 91. Shanghai Fosun Pharmaceutical?Group? Details, Company Type, Antispasmodics Drug Area Served and Its Competitors
Table 92. Shanghai Fosun Pharmaceutical?Group? Antispasmodics Drug Product Offered
Table 93. Shanghai Fosun Pharmaceutical?Group? Antispasmodics Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Shanghai Fosun Pharmaceutical?Group? Main Business
Table 95. Shanghai Fosun Pharmaceutical?Group? Latest Developments
Table 96. SunGen Pharma Details, Company Type, Antispasmodics Drug Area Served and Its Competitors
Table 97. SunGen Pharma Antispasmodics Drug Product Offered
Table 98. SunGen Pharma Antispasmodics Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. SunGen Pharma Main Business
Table 100. SunGen Pharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Antispasmodics Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antispasmodics Drug Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Antispasmodics Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Antispasmodics Drug Sales Market Share by Country/Region (2024)
Figure 8. Antispasmodics Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Antispasmodics Drug Market Size Market Share by Type in 2024
Figure 10. Antispasmodics Drug in Hospital
Figure 11. Global Antispasmodics Drug Market: Hospital (2020-2025) & ($ millions)
Figure 12. Antispasmodics Drug in Homecare
Figure 13. Global Antispasmodics Drug Market: Homecare (2020-2025) & ($ millions)
Figure 14. Antispasmodics Drug in Specialty Clinic
Figure 15. Global Antispasmodics Drug Market: Specialty Clinic (2020-2025) & ($ millions)
Figure 16. Antispasmodics Drug in Others
Figure 17. Global Antispasmodics Drug Market: Others (2020-2025) & ($ millions)
Figure 18. Global Antispasmodics Drug Market Size Market Share by Application in 2024
Figure 19. Global Antispasmodics Drug Revenue Market Share by Player in 2024
Figure 20. Global Antispasmodics Drug Market Size Market Share by Region (2020-2025)
Figure 21. Americas Antispasmodics Drug Market Size 2020-2025 ($ millions)
Figure 22. APAC Antispasmodics Drug Market Size 2020-2025 ($ millions)
Figure 23. Europe Antispasmodics Drug Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Antispasmodics Drug Market Size 2020-2025 ($ millions)
Figure 25. Americas Antispasmodics Drug Value Market Share by Country in 2024
Figure 26. United States Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Antispasmodics Drug Market Size Market Share by Region in 2024
Figure 31. APAC Antispasmodics Drug Market Size Market Share by Type (2020-2025)
Figure 32. APAC Antispasmodics Drug Market Size Market Share by Application (2020-2025)
Figure 33. China Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 37. India Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Antispasmodics Drug Market Size Market Share by Country in 2024
Figure 40. Europe Antispasmodics Drug Market Size Market Share by Type (2020-2025)
Figure 41. Europe Antispasmodics Drug Market Size Market Share by Application (2020-2025)
Figure 42. Germany Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 43. France Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Antispasmodics Drug Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Antispasmodics Drug Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Antispasmodics Drug Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Antispasmodics Drug Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 56. APAC Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 57. Europe Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 59. United States Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 60. Canada Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 61. Mexico Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 62. Brazil Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 63. China Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 64. Japan Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 65. Korea Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 67. India Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 68. Australia Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 69. Germany Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 70. France Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 71. UK Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 72. Italy Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 73. Russia Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 74. Egypt Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 75. South Africa Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 76. Israel Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 77. Turkey Antispasmodics Drug Market Size 2026-2031 ($ millions)
Figure 78. Global Antispasmodics Drug Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Antispasmodics Drug Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Antispasmodics Drug Market Size 2026-2031 ($ millions)